α-Helix 2 in the Amino-terminal Mad Homology 1 Domain Is Responsible for Specific DNA Binding of Smad3*

Smads, signal transducers of the transforming growth factor-β (TGF-β) superfamily proteins, directly bind to DNA and regulate transcription of target genes. Smad3 binds to CAGA box, whereas Smad1 and Smad5 preferentially bind to GC-rich sequences. The β-hairpin loop in the amino-terminal Mad homology 1 (MH1) domain is the direct DNA-binding site of Smad3; however, the amino acid sequences of the β-hairpin loop of Smad3 and Smad1/5 are identical, suggesting that other regions may be responsible for the differential DNA binding of Smad3 and Smad1/5. To identify regions other than the β-hairpin loop responsible for specific DNA binding of Smad3, we generated chimeras containing various regions of Smad3 and Smad1. Luciferase assays using a TGF-β-responsive reporter (CAGA)9-MLP-Luc and gel-mobility shift assays using 3xCAGA as a probe revealed that α-helix 2 (H2) in the amino-terminal part of the MH1 domain plays an important role in specific DNA binding and transcriptional activation of Smad3. Luciferase assays using natural TGF-β-responsive reporters also revealed the functional importance of H2 in the Smad3 MH1 domain in direct DNA binding. Smad3 thus binds to DNA directly through the β-hairpin loop, and H2 supports specific DNA binding of Smad3.

[1]  R. Fairman,et al.  Formation of a Stable Heterodimer between Smad2 and Smad4* , 2001, The Journal of Biological Chemistry.

[2]  R. Kucherlapati,et al.  Functional Characterization of Transforming Growth Factor β Signaling in Smad2- and Smad3-deficient Fibroblasts* , 2001, The Journal of Biological Chemistry.

[3]  K. Miyazono,et al.  Divergence and convergence of TGF‐β/BMP signaling , 2001, Journal of cellular physiology.

[4]  Kirby D. Johnson,et al.  Repression of Dpp Targets by Binding of Brinker to Mad Sites* , 2001, The Journal of Biological Chemistry.

[5]  Tomoki Chiba,et al.  Smurf1 Interacts with Transforming Growth Factor-β Type I Receptor through Smad7 and Induces Receptor Degradation* , 2001, The Journal of Biological Chemistry.

[6]  S. Newfeld,et al.  Transgenic analysis of the Smad family of TGF-beta signal transducers in Drosophila melanogaster suggests new roles and new interactions between family members. , 2001, Genetics.

[7]  C. Heldin,et al.  Transforming growth factor-beta induces nuclear import of Smad3 in an importin-beta1 and Ran-dependent manner. , 2001, Molecular biology of the cell.

[8]  Benoy M. Chacko,et al.  The L3 loop and C-terminal phosphorylation jointly define Smad protein trimerization , 2001, Nature Structural Biology.

[9]  Serhiy Souchelnytskyi,et al.  Regulation of Smad signaling by protein kinase C , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  R. Derynck,et al.  Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Wrana,et al.  Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. , 2000, Molecular cell.

[12]  Xia Lin,et al.  Smurf2 Is a Ubiquitin E3 Ligase Mediating Proteasome-dependent Degradation of Smad2 in Transforming Growth Factor-β Signaling* 210 , 2000, The Journal of Biological Chemistry.

[13]  Y G Chen,et al.  Engagement of bone morphogenetic protein type IB receptor and Smad1 signaling by anti-Müllerian hormone and its type II receptor. , 2000, The Journal of biological chemistry.

[14]  C. Heldin,et al.  Functional consequences of tumorigenic missense mutations in the amino-terminal domain of Smad4 , 2000, Oncogene.

[15]  Y. Chen,et al.  Structural basis for the functional difference between Smad2 and Smad3 in FAST-2 (forkhead activin signal transducer-2)-mediated transcription. , 2000, The Biochemical journal.

[16]  H. Lodish,et al.  A distinct nuclear localization signal in the N terminus of Smad 3 determines its ligand-induced nuclear translocation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[17]  S. Kern,et al.  Functional mapping of the MH1 DNA-binding domain of DPC4/SMAD4. , 2000, Nucleic acids research.

[18]  L. Attisano,et al.  Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. Massagué,et al.  Transcriptional control by the TGF‐β/Smad signaling system , 2000 .

[20]  K. Miyazono,et al.  Smad6 Is a Smad1/5-induced Smad Inhibitor , 2000, The Journal of Biological Chemistry.

[21]  K. Miyazono,et al.  Characterization of a bone morphogenetic protein-responsive Smad-binding element. , 2000, Molecular biology of the cell.

[22]  K. Kaestner,et al.  Unified nomenclature for the winged helix/forkhead transcription factors. , 2000, Genes & development.

[23]  Yan Chen,et al.  Regulation of Smad7 Promoter by Direct Association with Smad3 and Smad4* , 1999, The Journal of Biological Chemistry.

[24]  Jeffrey L. Wrana,et al.  A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation , 1999, Nature.

[25]  J. Gauthier,et al.  A short amino-acid sequence in MH1 domain is responsible for functional differences between Smad2 and Smad3 , 1999, Oncogene.

[26]  K. Miyazono,et al.  Drosophila dSmad2 and Atr‐I transmit activin/TGFβ signals , 1999, Genes to cells : devoted to molecular & cellular mechanisms.

[27]  K. Miyazono,et al.  Alternatively Spliced Variant of Smad2 Lacking Exon 3 , 1999, The Journal of Biological Chemistry.

[28]  Yigong Shi,et al.  Crystal Structure of a Smad MH1 Domain Bound to DNA Insights on DNA Binding in TGF-β Signaling , 1998, Cell.

[29]  C. Heldin,et al.  Identification and Functional Characterization of a Smad Binding Element (SBE) in the JunB Promoter That Acts as a Transforming Growth Factor-β, Activin, and Bone Morphogenetic Protein-inducible Enhancer* , 1998, The Journal of Biological Chemistry.

[30]  M. Frasch,et al.  Smad proteins act in combination with synergistic and antagonistic regulators to target Dpp responses to the Drosophila mesoderm. , 1998, Genes & development.

[31]  Takeshi Imamura,et al.  Smad proteins exist as monomers in vivo and undergo homo‐ and hetero‐oligomerization upon activation by serine/threonine kinase receptors , 1998, The EMBO journal.

[32]  P. Hoodless,et al.  Smad2 and Smad3 positively and negatively regulate TGF beta-dependent transcription through the forkhead DNA-binding protein FAST2. , 1998, Molecular cell.

[33]  Denis Vivien,et al.  Direct binding of Smad3 and Smad4 to critical TGFβ‐inducible elements in the promoter of human plasminogen activator inhibitor‐type 1 gene , 1998, The EMBO journal.

[34]  R. Mcinnes,et al.  The Tlx-2 homeobox gene is a downstream target of BMP signalling and is required for mouse mesoderm development. , 1998, Development.

[35]  A. Reddi,et al.  Role of morphogenetic proteins in skeletal tissue engineering and regeneration , 1998, Nature Biotechnology.

[36]  Yigong Shi,et al.  The L3 loop: a structural motif determining specific interactions between SMAD proteins and TGF‐β receptors , 1998, The EMBO journal.

[37]  Kohei Miyazono,et al.  TGF-β signalling from cell membrane to nucleus through SMAD proteins , 1997, Nature.

[38]  Kirby D. Johnson,et al.  Drosophila Mad binds to DNA and directly mediates activation of vestigial by Decapentaplegic , 1997, Nature.

[39]  J. Massagué,et al.  Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4 , 1997, Nature.

[40]  J. Wrana,et al.  The MAD-Related Protein Smad7 Associates with the TGFβ Receptor and Functions as an Antagonist of TGFβ Signaling , 1997, Cell.

[41]  L. A. Goldman,et al.  Modifications of vectors pEF-BOS, pcDNA1 and pcDNA3 result in improved convenience and expression. , 1996, BioTechniques.

[42]  D. Rifkin,et al.  An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. , 1994, Analytical biochemistry.

[43]  K. Lyons,et al.  Bone morphogenetic protein-3 is a negative regulator of bone density , 2001, Nature Genetics.